Company intelligence / Profile preview

Corestemchemon

Seongnam-si, Gyeonggi-do, South Koreacorestemchemon.com ↗
Ownership
Private
Employees
~355
Development stage
Commercial
01

Overview

Corestemchemon’s lead product, NEURONATA-R inj, is an autologous bone marrow mesenchymal stem cell therapy for ALS. The company has completed patient registration for a Phase 3 trial of NEURONATA-R and has received Expanded Access Program authorization from the US FDA. Other pipeline programs target neurodegenerative and autoimmune diseases and are in various preclinical or early clinical stages[2][3].

Therapeutic areas
ImmunologyNeurology
Modalities
Stem cell therapies (autologous bone marrow mesenchymal stem cells)[3][4]
Industry
Biotech
02

Drug pipeline

11 assets

CS20AT04

Approved

10 more assets in the full pipeline.

Request access →
03

Partnerships

NH Investment & Securities Co., Ltd.Samsung Securities Co., Ltd. provided significant funding.[4]No major pharma partnerships publicly disclosed.

Beyond the preview

Go deeper on Corestemchemon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corestemchemon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call